Effect of a platelet activating factor (PAF) antagonist on the hepatic afferent vascular occlusion
Fukuoka, T.; Nakajima, Y.; Matsumoto, M.; Nakano, H.; Shiratori, T.
Nihon Geka Gakkai Zasshi 89(5): 788
1988
ISSN/ISBN: 0301-4894 PMID: 3412312 Document Number: 323890
Document emailed within 1 workday
Related Documents
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Yue, T.L.; Farhat, M.; Rabinovici, R.; Perera, P.Y.; Vogel, S.N.; Feuerstein, G. 1990: Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits Journal of Pharmacology and Experimental Therapeutics 254(3): 976-981
Montrucchio, G.; Alloatti, G.; Mariano, F.; Tetta, C.; Emanuelli, G.; Camussi, G. 1986: Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist International Journal of Tissue Reactions 8(6): 497-504
Poveshchenko, A.F.; Kozlov, V.A. 1999: The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 53-56
Perico, N.; Delaini, F.; Tagliaferri, M.; Abbate, M.; Cucchi, M.; Bertani, T.; Remuzzi, G. 1988: Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney Laboratory Investigation; a Journal of Technical Methods and Pathology 58(2): 163-171
Toth, P.D.; Mikulaschek, A.W. 1986: Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat Circulatory Shock 20(3): 193-203
Brecht, H.M.; Adamus, W.S.; Heuer, H.O.; Birke, F.W.; Kempe, E.R. 1991: Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man Arzneimittel-Forschung 41(1): 51-59
Handley, D.A.; Van Valen, R.G.; Melden, M.K.; Houlihan, W.J.; Saunders, R.N. 1988: Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412 Journal of Pharmacology and Experimental Therapeutics 247(2): 617-623
Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Fernández-Gallardo, S.; Ortega, M.P.; Priego, J.G.; de Casa-Juana, M.F.; Sunkel, C.; Sánchez Crespo, M. 1990: Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies Journal of Pharmacology and Experimental Therapeutics 255(1): 34-39
Asai, Y. 2005: Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880 Die Pharmazie 60(3): 201-204
Wilson, D.V.; Patterson, J.S.; Stick, J.A.; Provost, P.J. 1994: Histologic and ultrastructural changes after large-colon torsion, with and without use of a specific platelet-activating factor antagonist (WEB 2086), in ponies American Journal of Veterinary Research 55(5): 681-688
Oztürk, H.; Oztürk, H.; Dokucu, A.I.; Otcu, S. 2006: Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats Acta Gastro-Enterologica Belgica 69(2): 197-202
Giudice, A.; Herbert, J.M.; Maffrand, J.P.; Manara, L.; Manzoni, L.; Le Fur, G. 1996: Prevention of platelet-activating factor-induced gastrointestinal lesions in rats by the new specific antagonist N-(2-dimethylaminoethyl)-N-(3-pyridinylmethyl)[4-(2,4,6-triisopropylphe nyl) thiazol-2yl]amine Arzneimittel-Forschung 46(4): 407-412
Cohen, M.L.; Robertson, D.W.; Bloomquist, W.E.; Wilson, H.C. 1992: LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis Journal of Pharmacology and Experimental Therapeutics 261(1): 202-208
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Lakin, K.M.; Kulikov, V.I.; Manevich, E.M.; Muliar, A.G.; Shvets, V.I. 1988: Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation Farmakologiia i Toksikologiia 51(4): 113-123
Peng, S-ying.; Zhang, F-ying.; Ou-Yang, X-yu.; Liu, Y.; Wang, W-jie. 2006: Effect of ginkgolide B on the platelet-activating factor induced changes of chemotaxis and cytoskeleton of macrophages Yao Xue Xue Bao 41(2): 156-160